Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stopping insulin injections following genetic testing in diabetes: impact on identity.

Diabetic medicine : a journal of the British Diabetic Association - 1 Jul 2010

Shepherd M

Abstract excerpt

BACKGROUND: Identification of genes causing monogenic diabetes has led to treatment change, from insulin to sulphonylureas for many previously considered insulin dependent. Changing treatment has led to improved glycaemic control and quality of life; however, the impact of a genetic diagnosis and consequent treatment change on identity has not been explored. METHODS: This paper examines the experiences of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 1
Share to Diagnosis, Differential
Share to Hypoglycemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin

Share to Interviews as Topic

Share to Longitudinal Studies

Share to Self Concept

Share to Sulfonylurea Compounds

Source

Identifiers

PMID: 20636966
DOI: 10.1111/j.1464-5491.2010.03022.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stopping insulin injections following genetic testing in diabetes: impact on identity.PMID 20636966Read ↗

'I put it on the back burner most days': Living with chronic risk.Semantic proximity Read ↗

The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis.Semantic proximity Read ↗

A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients.Semantic proximity Read ↗

Experiential knowledge of disability, impairment and illness: The reproductive decisions of families genetically at risk.Semantic proximity Read ↗

Experience of family function, family involvement, and self‐management in adult patients with type 2 diabetes: A thematic analysisSemantic proximity Read ↗

Inter-embodiment and the experience of genetic testing for familial hypercholesterolaemia.Semantic proximity Read ↗

Truths and Misinformation: A Qualitative Exploration of Myotonic DystrophySemantic proximity Read ↗

Assessment of Experience, Fears, Barriers and Adherence to Insulin Injection Among the Parents of Children with DiabetesSemantic proximity Read ↗

Reinforcing Loss and Rendering Invisible: Adoptee Experience and the Structural Failings of Biomedicine.Semantic proximity Read ↗

Maintaining an outward image: a Korean immigrant's life with type 2 diabetes mellitus and hypertension.Semantic proximity Read ↗

Patients’ experience of medication brand changes during hormone therapy for breast cancer. An Interpretative Phenomenological AnalysisSemantic proximity Read ↗

Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.